Cognitive Behavioral Therapy for Core Autism Symptoms in School-Aged Children: A Randomized, Controlled Trial
BIACA-2
1 other identifier
interventional
20
1 country
1
Brief Summary
This study is designed to examine the efficacy of a cognitive behavioral therapy (CBT) program for treating core autism symptoms, social and emotional problems, and adaptive behavior deficits in children with autism spectrum disorders.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_1
Started Sep 2008
Typical duration for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2008
CompletedFirst Submitted
Initial submission to the registry
November 12, 2008
CompletedFirst Posted
Study publicly available on registry
November 13, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2011
CompletedFebruary 5, 2013
February 1, 2013
3.2 years
November 12, 2008
February 1, 2013
Conditions
Outcome Measures
Primary Outcomes (1)
ADIS-C/P (Anxiety Disorder Interview Schedule for Children and Parents)
8 months (post-treatment)
Secondary Outcomes (1)
Behavioral observations of social responsiveness
8 months (post-treatment)
Study Arms (2)
CBT
EXPERIMENTALUsual Care
ACTIVE COMPARATORInterventions
16 weeks of community care, 16 weeks of CBT, 1.5 hours/week.
Eligibility Criteria
You may qualify if:
- years of age
- meet research criteria for a diagnosis of autism, Asperger Syndrome, or PDD-NOS
- meet DSM-IV criteria for one of the following anxiety disorders: Separation Anxiety Disorder, Social Phobia, Obsessive-Compulsive Disorder
- If taking medication, have maintained a stable dose for 1 month prior to baseline assessment
You may not qualify if:
- child has an IQ of less than 80
- begin taking new medication(s) or current medication dose changes either (1) less than 1 month prior to baseline assessment, or (2) during the study period
- for any reason the child or parents appear unable to participate in the treatment program
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UCLA
Los Angeles, California, 90095, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jeffrey Wood, PhD
University of California, Los Angeles
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
November 12, 2008
First Posted
November 13, 2008
Study Start
September 1, 2008
Primary Completion
December 1, 2011
Study Completion
December 1, 2011
Last Updated
February 5, 2013
Record last verified: 2013-02